Regulatory Updates

EUDAMED’s first four modules become mandatory on 28 May 2026 - what this means for medical device manufacturers

The European Commission (EC) has formally declared that the first four modules of EUDAMED - the European Database on Medical Devices - will become mandatory as of 28 May 2026.

MedNet EC-REP

Author

EUDAMED’s first four modules

Which modules are affected

Starting on 28 May 2026, the following modules will require compulsory use under Regulation (EU) 2024/1860:

  • Actor registration (registration of economic operators - manufacturers, authorised representatives, importers, etc.)
  • UDI/Devices registration (device registration and unique device identifier requirements)
  • Notified Bodies & Certificates (registration of notified bodies and associated device certificates)
  • Market Surveillance (module supporting oversight of devices on the market)

Timing and transition

The EC published the notice declaring functionality of these modules on 27 November 2025, triggering the mandated six-month transition period under the Regulation - hence the effective date of 28 May 2026.

Until that date, use of the modules remains voluntary, but after 28 May 2026 their use becomes a legal requirement for any responsible economic operator under MDR/IVDR.

Conclusions & Recommendations

  • The mandatory activation of the first four EUDAMED modules from 28 May 2026 signals a major shift toward increased transparency and regulatory compliance across the EU medical device market.
  • All manufacturers, authorised representatives, importers, and notified bodies should review their readiness - including internal processes and data - to ensure timely registration.
  • With our expertise, MedNet EC-REP GmbH can help navigate the transition smoothly. Contact your Regulatory Affairs Manager for further information.

Source: European Commission

Related Articles

Intended Purpose vs Intended Use
Regulatory Updates

Regulatory Affairs Bulletin: Intended Purpose vs Intended Use under MDR & IVDR

European regulations EU 2017/745 (MDR) and EU 2017/746 (IVDR) require precise definitions in technical documentation, and the distinction (or overlap) between intended purpose and intended use remains a topic of operational significance. This bulletin clarifies the regulatory definitions, their implications, and guidance interpretations.

MedNet EC-REP
Update to the Borderline & Classification Manual
Regulatory Updates

Implications of the Update to the Borderline & Classification Manual under MDR and IVDR

On 12 September 2025, the European Commission published Version 4 of the Manual on Borderline and Classification under Regulations (EU) 2017/745 and 2017/746, developed by the Borderline and Classification Working Group (BCWG). This updated manual provides revised guidance on determining whether a product is a medical device (or in vitro diagnostic device), dealing with borderline cases, and applying the classification rules under MDR and IVDR. Regulatory affairs professionals should be aware of both the new content and the practical implications for compliance.

MedNet EC-REP

Stay Updated

Get the latest regulatory updates and industry insights delivered to your inbox.

Subscribe to Updates